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Background: Neuropsychiatric affection involving extrapyramidal symptoms is a frequent component of Wilson’s
disease (WD). WD is caused by a genetic defect of the copper (Cu) efflux pump ATPase7B. Mouse strains with
natural or engineered transgenic defects of the Atp7b gene have served as model of WD. These show a gradual
accumulation and concentration of Cu in liver, kidneys, and brain. However, still little is known about the regional
distribution of Cu inside the brain, its influence on other metals and subsequent pathophysiological mechanisms.
We have applied laser ablation inductively coupled plasma mass spectrometry and performed comparative metal
bio-imaging in brain sections of wild type and Atp7b null mice in the age range of 11–24 months. Messenger RNA
and protein expression of a panel of inflammatory markers were assessed using RT-PCR and Western blots of brain
homogenates.
Results: We could confirm Cu accumulation in brain parenchyma by a factor of two in WD (5.5 μg g−1 in the
cortex) vs. controls (2.7 μg g−1) that was already fully established at 11 months. In the periventricular regions (PVR)
known as structures of prominent Cu content, Cu was reduced in turn by a factor of 3. This corroborates the view
of the PVR as efflux compartments with active transport of Cu into the cerebrospinal fluid. Furthermore, the
gradient of Cu increasing downstream the PVR was relieved. Otherwise the architecture of Cu distribution was
essentially maintained. Zinc (Zn) was increased by up to 40% especially in regions of high Cu but not in typical Zn
accumulator regions, a side effect due to the fact that Zn is to some degree a substrate of Cu-ATPases. The
concentrations of iron (Fe) and manganese (Mn) were constant throughout all regions assessed. Inflammatory
markers TNF-α, TIMP-1 and the capillary proliferation marker α-SMA were increased by a factor of 2–3 in WD.
Conclusions: This study confirmed stable cerebral Cu accumulation in parenchyma and discovered reduced Cu in
cerebrospinal fluid in Atp7b null mice underlining the diagnostic value of micro-local analytical techniques.
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Wilson’s disease (WD) is a disorder of copper (Cu)
disposition of autosomal recessive inheritance [1]. As a
consequence, excessive Cu accumulates in tissues and
causes organ damage and malfunction which is respon-
sible for the incidence of a wide spectrum of hepatic and
neuropsychiatric symptoms. The affected gene, i.e. Atp7b
is located on the long arm of human chromosome 13 and
encodes a Cu-transporting P-type adenosine triphospha-
tase, ATPase7B, which is beneath ATPase7A the second
known Cu efflux pump. In contrast to almost all other
nutrients, Cu passively enters the cell via channels such
as CTR1 and excess Cu is actively sequestered. In pola-
rized epithelial cell types forming inner surfaces such as
gut enterocytes, choroid plexus ependymocytes and also
capillary endothelial cells ATPase7A is localized to the
basolateral membrane and ATPase7B is localized to the
apical membrane [2]. While those contain both isoforms,
hepatocytes almost exclusively contain ATPase7B. Conse-
quently, ATPase7A is responsible for absorption of Cu
from the intestine into the blood or from the capillary
lumen into the tissue parenchyma while ATPase7B is re-
sponsible for sequestration of Cu into the bile, into the
cerebrospinal fluid or back from an organ parenchyma
into the circulation. Cu efflux may sequentially occur by
separate sequestration of Cu and Coeruloplasmin apopro-
tein into trans-Golgi vesicles, followed by formation of the
tight complex there and subsequent exocytosis. Although
Cu is an essential cofactor for a number of enzymes and
required for numerous cellular processes, Cu overload is
highly toxic resulting in oxidative damage and inflamma-
tion. Within the brain those WD patients with neurological
symptoms showed lesions or atrophia in the basal ganglia
and other regions [3]. To our knowledge no data is avail-
able on Cu concentrations in regions of post mortem hu-
man WD brain. The initial neurological symptoms of Cu
overload may be very subtle, such as mild tremor, as well
as speech and writing problems [4]. At the molecular level
these alterations are mainly caused by metal dependent
production of dangerous radical oxygen species and the
ability of Cu to affect the secretion of molecules involved
in the protection of neurons against oxidative stress [5].
There are several rodent models of Cu overload avail-
able that generate defects that closely resemble those
found in patients suffering from WD. Historically, the
first model described were Long-Evans cinnamon rats
that carry a transcriptional deficient Atp7b mutant in
which a deletion removes over 900 bp of the coding
region at the 3′ end that encodes the crucial highly
conserved ATP binding domain [6-8]. Similarly, the
toxic milk mutation in mice in which a single base
difference within the Atp7b gene causes hepatic accumu-
lation of Cu that can be 100-fold higher than that
observed in normal adults is also a well-accepted animalmodel for WD [9-11]. The respective phenotype of these
mice resembles in part that seen in patients with WD
[12]. A recent report has shown that the toxic milk mice
accumulate Cu in different regions of the brain resulting
in an approximately twofold higher mean brain Cu con-
centration at an age of 12 months than that observed in
age-matched control mice [13]. In addition, the same
study reported that the cerebral zinc (Zn) concentration
in 10 months animals was slightly higher than in control
mice and that further iron (Fe) accumulation was found
in the hippocampus of older animals. In this model,
elevated concentrations of Cu were mainly found in the
striatum, hippocampus and cerebellum but not in the
cerebral cortex [14]. These alterations were accompanied
by a mild impairment in the rotarod and cylinder tests
and further by a lack of acquisition of spatial memory in
the Morris water maze [14]. In this regard, the pheno-
type of toxic milk mice resembles the clinical symptoms
of patients suffering from WD. However, this model has
some limitations. First, brain lesions in 12-month-old
mice are not as advanced as in patients with the neuro-
logical form of WD [13]. Second, pups are born Cu-
deficient and the milk produced by mutant mothers
contains too low amounts of Cu resulting in early death, a
characteristic that is not seen in patients affected by WD
[9]. Moreover, morphologic and chemical studies of
hepatic Cu toxicosis indicated striking differences in mor-
phologic integrity between regenerative nodules and the
intervening parenchyma with profound changes in mito-
chondria, endoplasmic reticula, and nuclei as well as the
accumulation of microvesicular lipid droplets in injured
hepatocytes, again features that are not seen in patients
with WD [15]. In addition, despite a significant elevation
of Cu in the brain of the Cu-loaded toxic milk mice no
behavioral changes were observed in other studies [10]
raising some doubts about whether this model is appro-
priately mimicking WD [15].
Atp7b deficient mice that were generated by directed
genetic disruption display a gradual accumulation of hepatic
Cu that increases to a level 60-fold greater than normal by
5 months of age and develop cirrhosis of the liver, while
the progeny of homozygous mutant females are initially
characterized by neurological abnormalities and growth
retardation that is specific to Cu deficiency [16]. In addition,
it is known that these mice show an increase in Cu and Fe
concentration in the brain [16]. Interestingly, these mice
have further elevated hepatic and cerebral superoxide dis-
mutase activities indicating oxidative stress in respective
tissues that is combined with a severe dysfunction of
mitochondrial energy production [17].
Using quantitative positron emission tomography in
Atp7b deficient mice, it was demonstrated that injection
of 64CuCl2 intravenously resulted in increased accumula-
tion and markedly reduced clearance of Cu from the
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brain, kidneys, lungs, and heart compared to wild type
(WT) animals suggesting that the reduced 64Cu radio-
activity in the Atp7b null mice in extrahepatic tissues may
be caused by hepatic trapping of Cu [18]. Likewise, the
oral administration of radioactive CuCl2 was not able to
induce higher concentrations of Cu within brains of mice
that lack functional ATP7B protein [19]. These imaging
findings demonstrate that Cu homeostasis and distribu-
tion in different organs is differentially regulated.
Laser ablation inductively coupled plasma mass spec-
trometry (LA-ICP-MS) is a method capable of simulta-
neously detecting numerous metals and non-metals in
one sample at concentrations as low 0.1–1 μg g−1 for Mn,
Fe, Cu, Zn and 0.05–0.2 μg g−1 for lanthanides [20,21].
In the present study we performed LA-ICP-MS mea-
surements in brains isolated from Atp7b deficient mice
and respective controls. Furthermore, gene expression and
protein levels of a panel of inflammatory and blood vessel
proliferation markers were studied.
Results and discussion
Metal accumulation in the brain and liver is a well
known consequence of WD. Studies using magnetic res-
onance imaging have shown that patients with WD show
bilateral T2 hyperintensity involving thalami, cerebral
white matter, basal ganglia, cerebellum and brainstem
[22]. Cu loading studies in the toxic milk mouse model
(a natural defect of ATPase7B) have shown that there
are some chronological changes in tissue Cu loading that
also affect the bio-distribution of other metals [10]. A re-
cent publication analyzing this model has further shown
that the amount of Cu overload was unequally distri-
buted in different brain regions [14]. While the concen-
tration was increased in the striatum, hippocampus and
cerebellum, the concentration of Cu was unaltered inFigure 1 Schematic overview of the murine brain and position of the
scheme, the different regions and the architecture of the mouse brain are
from which horizontal cryosections were prepared. (B) A photomicrographthe cerebral cortex [14]. However, all these former stud-
ies used atomic absorption spectroscopy to measure
metal concentrations in total extracts of the brain or its
different areas and a more precise study of Cu distribution
in brain and its impact on the cerebral concentration of
other metals or metalloids is presently not available in any
experimental models of WD.
Recently, we have shown that metal bio-imaging via
LA-ICP-MS is a novel, highly sensitive innovative diag-
nostic tool that allows simultaneous measurement of
over fifty different metal concentrations in liver tissue
with a high sensitivity, spatial resolution, specificity, and
quantification ability [23,24]. We here used this method-
ology to get more insight into the cerebral distribution
of various metals during progression of WD. To do so,
we comparatively imaged brain sections of WT and
Atp7b deficient mice at different ages by LA-ICP-MS.
The horizontal sections analyzed contained cortex, corpus
callosum, hippocampus, colliculus superior, cerebellum
and all four ventricules in all cases, colliculus inferior in
most cases, striatum, thalamus and brain stem structures
in some cases (Figure 1).
Since numerous findings have already uniformly sug-
gested that neuropathological alterations such as found in
Alzheimer’s disease, Down syndrome, Parkinson’s disease,
multiple sclerosis, and many other neurodegenerative
disorders are characterized or even causatively driven by
altered expression of IL-1β [25-27], we first comparatively
tested the mRNA expression of this cytokine in WT and
Atp7b deficient mice (Additional file 1: Figure S1A). In
contrast to all these previous reports, we found that the
IL-1β mRNA quantities were only slightly but not
significantly elevated in WD vs. controls. TNF-α mRNA
expression, in turn, was significantly increased more
than two-fold in WD. TNF-α is associated with damage
of myelin, oligodendrocytes and astrocytes [28,29] andsectional plane used for preparing cryosections. (A) In the
depicted. The red lines mark the position for sectioning and the region
of a representative cryosection used for imaging is shown.
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this hypothesis, we found increased expression of the
NLRP3 and ASC inflammasome components in the brains
of WD mice. Those components have important roles in
the pathology of microglia-specific formation of neuro-
degenerative disorders and further regulate CNS inflamma-
tion and de-myelination during cerebral insult [31,32]. This
finding again demonstrates that affected mice have exacer-
bating CNS inflammatory activity within their brains.
In addition, both, the tissue inhibitor of metalloproteinase-
1 (TIMP-1) and the matrix metalloproteinase 9 (MMP-9)
that represent biomarkers for the presence or extent of
brain injury and are necessary for the clearance of amyloid
[33,34] were expressed at higher levels in Atp7b deficient
brains. Since MMPs promote blood–brain barrier leakage,
it is possible that the elevated expression of MMP-9 may
already indicate existing brain cell dysfunction and
cerebral cell death [35].
We next performed Western blot analysis and found
that the expression of α-smooth muscle actin (α-SMA)
in protein extracts prepared from the brains of Atp7b
knockout mice (cf. Figure 1) was significantly higher
(Additional file 1: Figure S1B). In normal brain tissue,
α-SMA is generally undetectable and it was previously
supposed that α-SMA should be considered as a marker
for smooth muscle cell differentiation, which in the brain
becomes detectable in areas with microvascular prolifera-
tion [36]. Again, these findings indicate that the Atp7b
nulls already show signs of cerebral dysfunction. The in-
creased activation of inflammatory pathways within the
brains that we have already observed at the transcriptional
level was also noticeable in the elevated concentration of
the lipocalin 2 (LCN2) in older animals that lack Atp7b.
We have recently demonstrated that the upregulation of
LCN2 is a reliable indicator of organ damage that is sig-
nificantly correlated to inflammation [37,38]. Altogether,
our gene and protein expression data indicate that the
Atp7b deficient mice have some cerebral alterations that
are characteristic for WD in humans.
LA-ICP-MS simultaneously yielded images of the 28 pre-
selected m/z. Amongst these elements we first inspected
the distribution of sodium and phosphorus within the
brains of WT and Atp7b deficient mice in cryosections
with a thickness of 30 μm (Figure 2) [39] resulting in a
maintained architecture of these elements. In the un-
changed physiological situation highest concentrations
of phosphorus (up to 3,000 μg g−1) were found in the
granular layer of the cerebellum forming the shape of
the arbor vitae, the granular layer of the olfactory bulb,
in the intrastriatal and intracollicular fiber bundles and
corpus callosum (Figure 2). Sodium in the well known
manner showed the distribution of water with higher
concentrations in grey matter 800 μg g−1 compared to
white matter 600 μg g−1. Inversely, 13C ion intensitiesreflected the distribution of dry organic matter congru-
ent with the distribution of the fatty white matter. Next
manganese (Mn), Fe, Cu and Zn were assessed quantita-
tively in the regions of interest exemplarily depicted in
Figure 3. Average concentrations read out from large
regions are given in Table 1 and those of small hippocam-
pal regions in Table 2. While Fe and Mn were unchanged
and of perfectly preserved distributional architecture a
tremendous increase of Cu was already obvious from
visual inspection (Figures 4 and 5). At a second glance the
decrease of Cu in the periventricular regions was obvious,
especially in the fourth ventricule where a lumen was sys-
tematically discernable in WD animals but not in controls.
Otherwise the physiological distribution pattern of Cu was
maintained. This metal is the element presenting the high-
est range of physiological concentrations. In WT controls
Cu ranged from a minimum in callosal white matter of
1.5 μg g−1 to 67 μg g−1 in the fourth ventricule. In the other
grey matter components Cu occurs in quite low concen-
trations such as 2.7 μg g−1 in the cortex and 3.3 μg g−1 in
the colliculus superior. Somewhat higher Cu was observed
in the stratum moleculare of the fascia dentata (5.2 μg g−1),
the preasubiculum (4.8 μg g−1) and in the glomerular layer
of the olfactory bulb. Within the isocortex Cu was slightly
higher in the layers 2, 3 and 6. For validation additional 3
WD mice vs. 3 age-matched controls were studied by the
generation of quantitative images only but not by region of
interest based analysis. Here especially high quality Mn
images were obtained and all above mentioned findings
could be reproduced (Additional file 2: Figure S2).
Quantitative analysis confirmed an almost proportional
increase of Cu by 50%-130% in the brain parenchyma of
Atp7b deficient animals without further obvious syste-
matic between more or less Cu rich regions. This finding
reached significances of p = 0.00004 fulfilling even the
most conservative Bonferroni criteria. In the periventricu-
lar regions in turn Cu was decreased by factors of 2.3 in
and around ventricules I-III and of 3.5 around ventricule
IV. Interestingly, also the gradient of Cu concentrations
increasing downstream from lateral over third to fourth
ventricule was relieved. In the choroid plexus the cerebro-
spinal fluid (CSF) is produced essentially by ultrafiltration
through fenestrated capillaries. A part of the initially co-
filtrated Cu is immediately re-absorbed through ependy-
mocytes which express high amounts of ATPase7A at
their basolateral membrane. Ependymocytes of the
ventricular walls sequester Cu from brain parenchyma to
the CSF via ATPase7B localized at their apical portion. It
is fully compatible with the view of periventricular regions
as Cu efflux compartments that a lack of function of
ATPase7B leads to a decrease of Cu there.
Zn was increased by up to 40% especially in regions of
high Cu such as the stratum moleculare of the fascia
dentata or Cu rich areas of the cerebellum but not in
wild type
10 months 24 months
Atp7b -/-
10 months 24 months
C
Na
P
C
Na
P
Figure 2 Bioimaging of sodium and phosphate in the murine brain. Thin brain section of WT (upper panel) and Atp7b deficient mice (lower panel)
were prepared by cryo-cutting and analyzed for Na and P content by LA-ICP-MS. In these measurements, the metal intensities were normalized to the
average 13C ion intensity in respective samples. The photomicrographs of the analyzed cryo-sections are depicted for orientation.
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Figure 3 Regions of interest. Exemplarily different regions of the
murine brain in which metal content was measured by LA-ICP-MS
and quantified (see also Tables 1 and 2) are depicted.
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multiforme of the fascia dentata and the CA3 segment
of the pyramidal layer of the cornu ammonis, a side
effect due to Zn being to some degree a substrate of
Cu-ATPases. On the other hand a significant increase
of Zn was observed in the Zn rich ectorhinal cortex
(from18.8 in WT to 25.6 μg g-1 in WD, p = 0.008) and
anterior cingulate cortex (from 18.3 in WT to 23.2 μg g-1
in WD, p = 0.009).
To avoid potential misinterpretation of results that
may occur from animal-to-animal variations, we further
performed confirmatory measurements in additional 3
WD and 3 WT controls that were at age of 19–24
months. The visual inspection of the images that were
generated by the in house written Excel algorithm for
visualization of metal concentrations (see Methods) re-
sults in similar images that confirmed our measurements
(Additional file 3: Figure S3 and data not shown). There-
fore, these measurements were not further submitted to
region of interest based analysis.
When it comes to variation of metal concentrations
with age, the number of sections and animals submitted
to quantitative data analysis here is too small for final
conclusions. However, it can already be stated that in
this sample the full extent of altered Cu disposition was
already reached at 11 months and concentrations of Cu,
Zn and Mn rather slightly fall with age while Fe was
constant in WD. The more interesting period from 0 to
11 months was not covered by this sample. Here, in a
previous study in which selected elements were quanti-
fied by atomic absorption spectroscopy [17] some of usreported a progressive increase of Cu and Zn. The ani-
mals used were aged 3, 6, and 47 weeks (7 animals per
group). Fe had reached its full level already in 6 week
old mice [17].
Based on our findings, we could confirm that the homo-
zygous Atp7b deficient mice used in our study accumulate
cerebral Cu. A previous study that has reported the es-
tablishment of the respective animal model has already
demonstrated by use of polarized atomic absorption
spectrophotometry of dried tissue samples that the levels
of Cu in brain of homozygous mutant animals increased
slightly throughout adult life from 12.6 ± 6.8 to 36 ± 4 μg g−1
dry weight [16]. In human WD [40], the functionality con-
trolled by regions such as the basal ganglia, namely stri-
atum and pallidum is tremendously affected potentially
indicating that the observed alterations might be a direct
consequence of Cu deposits there [4]. In line with this, the
olfactory bulb that is located in the forebrain contains
specialized sensory cells and interneurons responsible for
accurate transmission of smell information [41]. In WD
patients with neurological symptoms a significant irrever-
sible olfactory dysfunction that correlates with Cu content
is documented [42]. It was recently demonstrated that in-
creased brain Cu in the toxic milk mice model correlated
well with the expression of inflammatory markers and
behavioral changes [14]. Immunohistochemical determin-
ation of ATP7B protein in brain tissue of rats has shown
that this Cu-transporting P-type ATPase was highly
expressed in neuronal cells of the hippocampal formation,
olfactory bulbs, cerebellum, cerebral cortex and nuclei in
the brainstem [43]. The finding that Cu is also enriched in
the cerebral cortex when Atp7b is absent confirms the hy-
pothesized essential role of this gene in the local export of
Cu from cells [44].
Somewhat in contrast to our findings is the observa-
tion that intravenous injection of 64CuCl2 via the tail
vein resulted in consistently lower Cu radioactivity at all
times in the brain of Atp7b knockout mice as compared
to control mice when analyzed by quantitative positron
emission tomography [19]. In this context, it has to be
well discriminated that this PET study measured the up-
take and turnover but not the total inventory of Cu as it
was the case in our study. Bio-distribution studies with
application of radio-Cu at lifetime, victimization after
hours and few days and autoradiography of brain sec-
tions clearly localized the fastest and highest uptake of
Cu to the periventricular regions [45]. Thus lower up-
take of Cu into periventricular regions in WD is per-
fectly in line with the finding of lower Cu there in this
study in WD mice.
Another report that was conducted in the toxic milk
mouse model on the C3H background has demonstrated
that the Cu accumulation was mainly found in striatum,
hippocampus and cerebellum, but unaltered in cerebral
Table 1 Average concentration of Fe, Cu, Zn and Mn in
large regions of the brain
μg g−1 wet weight Control WD %** change p- value
Entire section
Fe 14.1 ± 2.5 14.1 ± 1.0 .9
Cu 4.2 ± 1.4 6.7 ± 1.5 +61% .0007
Zn 13.2 ± 3.1 15.8 ± 1.7 +19% .07
Mn 0.25 ± 0.07 0.26 ± 0.05 .4
Cortex (grey matter)
Fe 12.4 ± 2.2 12.1 ± 0.8 .7
Cu 2.7 ± 0.7 5.5 ± 1.2 +108% .00004
Zn 13.9 ± 3.0 17.7 ± 0.8 +28% .008
Mn 0.23 ± 0.06 0.26 ± 0.04 .2
Corpus callosum (white matter)*
Fe 7.8 ± 1.1 7.6 ± 0.6 .6
Cu 1.5 ± 0.5 2.9 ± 0.8 +102% .0004
Zn 8.2 ± 2.1 9.5 ± 1.4 .2
Mn 0.11 ± 0.03 0.13 ± 0.04 .2
Cerebellum, Cu rich regions lobules 4–5, 8-10
Fe 17.4 ± 3.8 17.4 ± 2.1 1
Cu 6.6 ± 1.6 10.9 ± 1.7 +64% .0001
Zn 13.0 ± 2.9 16.0 ± 2.0 +23% .03
Mn 0.28 ± 0.09 0.28 ± 0.04 .9
Cerebellum Cu poor regions (other)
Fe 17.8 ± 3.5 16.3 ± 3.8
Cu 3.8 ± 0.9 7.5 ± 1.6 +95% .0002
Zn 12.3 ± 2.7 13.8 ± 3.1 .3
Mn 0.30 ± 0.08 0.27 ± 0.06 1
Cerebellar white matter*
Fe 8.4 ± 1.9 6.9 ± 1.9 .1
Cu 1.7 ± 0.3 4.0 ± 1.2 +132% .0004
Zn 6.8 ± 1.4 7.9 ± 1.2 .1
Mn 0.15 ± 0.04 0.13 ± 0.06 .9
Colliculus superior
Fe 13.8 ± 2.2 13.3 ± 1.1 .7
Cu 3.3 ± 0.7 6.1 ± 0.5 +85% .0005
Zn 9.8 ± 2.0 11.4 ± 0.4 .08
Mn 0.31 ± 0.07 0.34 ± 0.07 .3
Colliculus inferior
Fe 15.7 ± 3.4 12.1 ± 1.5 .05
Cu 3.6 ± 0.9 5.4 ± 0.7 +49% .003
Zn 9.5 ± 2.1 11.2 ± 1.7 .1
Mn 0.36 ± 0.10 0.35 ± 0.09 .06
Table 1 Average concentration of Fe, Cu, Zn and Mn in
large regions of the brain (Continued)
Periventricular regions
Lateral ventricules
Cu 39 ± 17 17 ± 3 −56% .01
Third ventricule
Cu 50 ± 28 22 ± 4 −57% .02
Fourth ventricule
Cu 67 ± 22 19 ± 5 −71% .0004
Concentrations of Fe, Cu, Zn, Mn (mean ± SD) measured by imaging LA-ICP-MS
in regions of interest in the brain of 8 controls, and 9 WD mice, both on a
SVJ129 background. Of each animal, one section was measured whereby each
hemisphere was measured in an independent run with separate calibration
standard. SD and heteroskedastic t-tests were calculated over the 8 and 9
individual bi-hemispheric averages.
*white matter borders were delineated to minimize spillover from neighbour
regions.
**indicated, if > +10% or < −10% and p < .05.
Boaru et al. BMC Neuroscience 2014, 15:98 Page 7 of 13
http://www.biomedcentral.com/1471-2202/15/98cortex [14]. The latter finding may be explained by a sys-
tematic contamination/mix-up of dissected cortical ma-
terial with periventricular material (lateral ventricles)
and thus wrongly high cortical Cu levels in controls.
These mice showed motor and cognitive disturbances
most likely because of the Cu deposition and inflamma-
tory response observed in the striatum.
Similarly, accumulation of Fe in the brain of aged LEC
rats (also bearing a defect of ATPase7B) was reported
previously with highest levels in the striatum and the
substantia nigra [46].
There is no doubt that the LA-ICP-MS imaging technol-
ogy used in this study is transferable to other experimental
models, organs, species, and various metal overload
diseases. We here used mouse that lacked the plasma
membrane Cu-transport protein ATP7B. In future it will
be interesting for us to visualize the metal content in sup-
plementary rodent models of WD including the toxic milk
mouse model or the Long-Evans cinnamon rats by LA-
ICP-MS. In addition, recent reports have provided strong
evidence that Cu metabolism Murri domain-containing
protein 1 (COMMD1)-deficiency in dogs lead to hepatic
Cu accumulation with a WD-like phenotype [47]. Also
these models in conjunction with LA-ICP-MS will help to
increase the knowledge in the pathogenesis of neuro-
degenerative disorders that occur during the course of
metal accumulation.
Conclusions
Our study evidenced an about 2-fold stable increase of
Cu throughout brain parenchyma in ATPase7B null
mice more or less proportional across the regions
assessed maintaining the characteristic distribution pat-
tern while in periventricular regions Cu was decreased
by down to a factor of 3.5. As Cu was increased propor-
tionally throughout all cerebral regions the regionally
Table 2 Average concentration of Fe, Cu, Zn and Mn in
small hippocampal regions of the brain
μg g−1 wet weight Control WD % change p- value
Fascia dentata, layers
Moleculare
Fe 13.1 ± 2.1 14.6 ± 1.2 .1
Cu 5.2 ± 1.2 8.9 ± 1.2 +71% .00001
Zn 14.0 ± 3.7 19.4 ± 1.3 +38% .004
Mn 0.34 ± 0.10 0.32 ± 0.07 .9
Granulare
Fe 18.4 ± 3.4 16.3 ± 2.1 .2
Cu 4.1 ± 1.1 7.6 ± 1.0 +86% .00001
Zn 25 ± 7 32 ± 3 +30% .02
Mn 0.39 ± 0.14 0.39 ± 0.09 .7
Multiforme /polymorph
Fe 12.9 ± 1.7 13.2 ± 0.8 .7
Cu 4.1 ± 1.2 8.0 ± 1.5 +95% .0001
Zn 47 ± 14 59 ± 9 +24% .1
Mn 0.48 ± 0.28 0.48 ± 0.14 .8
Cornu ammonis, layers
Oriens
Fe 10.8 ± 1.2 10.6 ± 1.0 .7
Cu 3.8 ± 0.8 6.6 ± 1.4 +75% .0002
Zn 18.0 ± 4.0 20.8 ± 3.8 .2
Mn 0.26 ± 0.06 .32 ± 0.08 .04
Pyramidale, CA3
Fe 11.3 ± 1.9 12.3 ± 1.4 .3
Cu 4.6 ± 1.4 7.0 ± 1.2 +52% .003
Zn 33 ± 10 38 ± 5.5 .2
Mn 0.45 ± 0.20 0.48 ± 0.13 .5
Pyramidale, CA1-2
Fe 19.0 ± 3.7 15.1 ± 1.5 .03
Cu 3.5 ± 1.0 5.9 ± 0.9 +69% .0002
Zn 20.9 ± 4.8 24.4 ± 3.4 .1
Mn 0.27 ± 0.07 0.33 ± 0.06 .04
Radiatum
Fe 10.5 ± 1.5 10.2 ± 0.7 .7
Cu 3.2 ± 0.8 6.3 ± 1.2 +92% .00002
Zn 21.8 ± 4.9 23.8 ± 3.0 .3
Mn 0.25 ± 0.06 0.31 ± 0.08 .04
Lacunosum- moleculare
Fe 12.8 ± 2.1 12.2 ± 1.3 .6
Cu 3.6 ± 0.9 5.6 ± 1.0 +53% .001
Zn 14.1 ± 3.7 18.4 ± 1.5 +30% .01
Mn 0.28 ± 0.08 0.29 ± 0.06 .4
Table 2 Average concentration of Fe, Cu, Zn and Mn in
small hippocampal regions of the brain (Continued)
Subiculum
Fe 14.4 ± 2.3 12.9 ± 1.4 .2
Cu 3.4 ± 0.9 5.9 ± 1.1 +72% .0001
Zn 15.4 ± 4.1 17.4 ± 1.6 .2
Mn 0.23 ± 0.06 0.27 ± 0.03 .7
Praesubiculum
Fe 13.9 ± 3.2 13.8 ± 1.5 1
Cu 4.8 ± 1.4 7.8 ± 1.4 +62% .0006
Zn 13.1 ± 3.0 16.3 ± 1.0 +25% .02
Mn 0.23 ± 0.07 0.26 ± 0.05 .2
Concentrations of Fe, Cu, Zn, Mn (mean ± SD) measured by LA-ICP-MSI in
subregions of the hippocampal formation. Layers are given in the order from
outside to inside.
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rather result from differential regional susceptibility to
Cu than from differential affection of Cu-efflux.
Zn was increased by 10%-40%. It is now tempting to
assess horizontal sections at a deeper level covering the
candidate structures pallidum, striatum and brain stem
nuclei and completing cohort by animals of younger ages.
Animal models deficient in Cu transporters and LA-ICP-
MS imaging are a setting perfectly suited to study thera-
peutic interventions for normalizing Cu disposition and
also studying their side effects on other metals, namely
Zn. In a wider perspective, this study demonstrates the su-
periority of microlocal analytical techniques over the study
of homogenates especially if regions or layers of highly
differential analyte concentrations are closely adjacent
which cannot be dissected reliably from each other. LA-
ICP-MS imaging is an important novel method that will
be helpful in the setting of experimental and clinical
research. This method will be easily transferable to other
models, organs and diseases and will have a strong influ-
ence on basic research and diagnostics in the near future.
Methods
Animals
The characteristics of Atp7b null mutation mice that
were used in this study are described elsewhere [16]. In
brief multiple stop codons covering all possible reading
frames were inserted into exon 2 of the Atp7b gene. The
transgenic −/− mice express the respective mRNA which
is not translated at all into full length functional protein
but into considerable smaller non functional proteins.
Mutant mice and age-matched controls had a genetic
129/Sv background and were housed at the University of
Heidelberg, according to the guidelines of the Institu-
tional Animal Care and Use Committees and in accor-
dance with governmental requirements [17]. For our
study, we analyzed a total of 17 animals (controls n = 8;
wild type
10 months 24 months
Atp7b-/-
10 months 24 months
C
Cu
Fe
Zn
C
Cu
Fe
Zn
Figure 4 Age-dependent cerebral accumulation of copper in Atp7b−/− mice as demonstrated by LA-ICP-MS. 30 μm thick cryosections
from WT (upper panel) and Atp7b−/− mice (lower panel) at age between 10 and 24 months were subjected to LA-ICP-MS imaging. The content of
carbon that served as reference in this analysis is given in %, while the total concentrations of Cu, Zn, and Fe are given in μg g−1 tissue.
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Figure 5 High resolution imaging of copper within the brain of age-matched wild type and Atp7b deficient mice. Brain sections of a
WT (upper panel) and Atp7b deficient mice (lower panel) were prepared from age-matched (~11 months) old animals and subjected to LA-ICP-MS
imaging to estimate the content of copper. Carbon served as an internal standard in this analysis.
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Confirmatory additional 3 WD mice and 3 controls, aged
19–24 months were analyzed up to the level of quantita-
tive element images but not submitted to region of inter-
est based analysis.
RNA isolation and quantitative real time PCR
RNA from total brain tissue was isolated by the guanidine
thiocyanate/CsCl method, followed by DNAse digestion
using the Purelink RNA Mini Kit system (Invitrogen, Life
Technologies, Darmstadt, Germany). Total RNA was
quantified and 2 μg samples were reversely transcribed
using Superscript II reverse transcriptase and random
hexamer primers (both from Invitrogen). For the indi-
vidual TaqMan PCR assays, the cDNA derived from
25 ng RNA was amplified in 25-μl volume using qPCR
Core Kits (Eurogentec, Cologne, Germany) and primer
combinations given in Additional file 4: Table S1. The
amplification of all respective target gene sequences
were done as follows: melting at 95°C for 10 min and
then 40 cycles at 95°C for 15 sec and 60°C for 1 min,
respectively. All samples were normalized to the expres-
sion of GAPDH.
Western blot analysis
Protein extracts from brain tissue were prepared following
standard protocols. Equal amounts of proteins (25 μg)
were heated at 80°C for 10 min and separated in 4-12%
Bis-Tris gels (Invitrogen) under reducing conditions.
Proteins were then electro-blotted on nitrocellulose mem-
branes (Schleicher & Schuell, Dassel, Germany). Successful
protein transfer and equal protein loading was monitored
via Ponceau S stain. Unspecific binding sites were blockedin TBST [10 mM Tris/HCl, 150 mM NaCl, 0.1% (v/v)
Tween 20, (pH 7.6)] containing 5% (w/v) non-fat milk
powder and the membranes were subsequently probed
with the antibodies given in Additional file 5: Table S2.
Primary antibodies were detected with horseradish-peroxidase
(HRP)-conjugated secondary antibodies (Santa Cruz, Santa
Cruz, CA) and the Supersignal chemiluminescent substrate
(Perbio Science, Bonn, Germany).
LA-ICP-MS imaging of trace metals in murine brain sections
In the experimental setup, a quadrupole-based inductively
coupled plasma mass spectrometer (ICP-MS, XSeries 2,
Thermo Scientific, Bremen, Germany) was coupled to a
laser ablation system (NWR 213, New Wave Research,
Fremont, CA, USA). For metal imaging, native sections
of mouse brains (30 μm thickness) were prepared and
thaw mounted onto Starfrost™ adhesive slides. Laser
ablation of biological tissue was performed as described
before [23] in continuous line ablation mode in pure
argon atmosphere at 36% output energy, 60 μm spot
size and 30 μm residual between lines making a y-pixel
dimension of 90 μm. The ablated material was trans-
ported by Ar into the inductively coupled plasma (ICP).
Sample gas flow was 1.1 L/min, auxiliary gas flow 0.7 L/min
and cooling gas flow 14 L/min. The ions formed in
the atmospheric pressure ICP were extracted in the
ultrahigh vacuum mass spectrometer via a differential
pumped interface, separated in the quadrupole mass
analyzer according to their mass-to-charge ratios and
detected by an ion detector. The sum of dwell times of
28 m/z for one cycle was 0.341 s thus making an x-pixel
dimension of 70 μm s−1 × 0.341 s = 24 μm. For quantifi-
cation purposes, matrix-matched laboratory standards
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concentrations were prepared as described previously
[20,23,24,48]. Also LA-ICP-MS parameters were opti-
mized in an established way [48]. To validate the metal
ion images, two isotopes of the same element were sim-
ultaneously analyzed when possible. Of each animal,
one section was measured whereby each hemisphere
was measured in an independent run with a separate
calibration standard. Images were reconstructed and
calibrated using an in house written Excel algorithm for
visualization (Figures 2, 3, 4 and 5, Additional file 2:
Figure S2) whereby the average net 13C ion intensity, as a
surrogate of slice thickness [48], was determined from his-
tograms of pixel values and served for normalizing metal
intensities. In an independent approach for validation, raw
data were reconstructed into 8 bit grayscale TIFF and,
when necessary, linearly drift corrected (the end of the
sample next to the standard was kept at a factor of 1 and
the correction factor progressively increased or decreased
line by line towards the other end) using IMAGENA [49].
The regions of interest including glass background and
entire section were defined and average ion intensities
read out using Pmod 3.1 (Pmod, Zurich, Switzerland).
The observer blinded careful manual delineation of neu-
roanatomically defined regions of interest used the mutual
information from C, P, Mn, Fe, Cu, Zn images, the micro-
photograph obtained before ablation and the RB4 Watson
Paxinos Atlas (download link: http://www.callisto-science.
org/NSI/Neuroscience_Image_Database/RUN_RBSC.PDF).
Standard measurements were processed by an Excel
algorithm yielding slope of the calibration curve. Data
were calibrated according to concentration = (maximum
counts –minimum counts) × (Ion intensity-background)/
(255 × slope). In the present series normalization of
sample and standard to the respective net average 13C ion
intensity produced the same group averages but a higher
scatter of individual results. Therefore, non 13C normalized
data are given as numeric results.
Statistics
Standard deviations, averages, % change vs. controls and het-
eroscedastic t-tests for independent samples over the 9 vs. 8
individual bi-hemispheric averages of regional element
concentrations were calculated using Excel. The classical
Bonferroni threshold for 21 regions×4 elements was p=
0.0006. For the Holmes modified Bonferroni correction the sig-
nificance threshold for the first region was considered at p=
0.05, for the second 0.05/2, for the third 0.05/3 and so on.
Additional files
Additional file 1: Figure S1. Comparative analysis of gene and protein
expression in brains of wild type and Atp7b-/- mice. (A) Relative mRNA
expression of IL-1β, TNF-α, NLRP3, ASC, TIMP-1 and MMP-9 expression inbrain of WT and Atp7b deficient mice. Significance levels in this analysis
are: a≤0.05, b≤0.02, and c≤0.01, respectively. (B) Western blot analysis of
TNF-R1, α-SMA, LCN2, and TIMP-1 in WT and Atp7b-/- mice. Brain protein
extracts were prepared as outlined in Methods. The expression of β-actin
served as a control for equal loading.
Additional file 2: Figure S2. Reproducibility of LA-ICP-MS measurements
in brain tissue. 30-μm thick brain cryo-cuts were prepared from several
of the same animals depicted in Figures 2 and 4. The specimens were
subjected to LA-ICP-MS measurements using the same experimental
setup. Please note the different concentration bars that are ranging from
0-1% for carbon, 0 - 2000 μg g-1 for sodium, 0 - 3000 μg g-1 for phosphate,
0 - 20 μg g-1 for Cu, 0 - 50 μg g-1 for Fe, 0 - 50 μg g-1 for Zn, 0- 0.2 μg g-1
for lead, and 0- 0.5 μg g-1 for Mn, respectively.
Additional file 3: Figure S3. Confirmatory analysis. To avoid errors
occurring from animal-to-animal variations, we confirmed our data in
additional 3 WD and 3 WT controls. Animals that were subjected to this
analysis were aged 19-24 months and images were visually analyzed but
not submitted to region of interest based analysis. Representative images
of carbon, Cu, Fe and Zn are depicted.
Additional file 4: Table S1. Primers used in this study.
Additional file 5: Table S2. Antibodies used in this study.
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